<?xml version="1.0" encoding="UTF-8"?>
<p>Preceding disruption by IE1, IE2 co-localizes with PML bodies, most likely as a consequence of binding to the viral genome which also associates with these organelles [
 <xref rid="B251-viruses-12-00110" ref-type="bibr">251</xref>,
 <xref rid="B253-viruses-12-00110" ref-type="bibr">253</xref>,
 <xref rid="B254-viruses-12-00110" ref-type="bibr">254</xref>]. However, IE2 is not currently considered an antagonist of PML bodies. Having said that, both IE1 and IE2 target histone modifying enzymes (see 
 <xref ref-type="sec" rid="sec3dot2-viruses-12-00110">Section 3.2</xref>), some of which are bona fide restriction factors, and more cellular mediators of intrinsic antiviral immunity targeted by the IE proteins will likely emerge in the future.
</p>
